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Abstract: Nuclear factor kappa B (NF-kB) and activating protein-1
(AP-1) transcription factors are ubiquitously expressed signaling
molecules known to regulate the transcription of a large number of genes
involved in immune responses, namely the inducible isoform of nitric
oxide synthase (iNOS). In this study, we demonstrate that a fetal
skin-derived dendritic cell line (FSDC) produces nitric oxide (NO) in
response to the contact sensitizer nickel sulfate (NiSO4) and increases the
expression of the iNOS protein, as determined by immunofluorescence
and Western blot analysis. The sensitizer NiSO4 increased cytoplasmic
iNOS expression by 31.9+ 10.3% and nitrite production, as assayed by
the Griess reaction, by 27.6+ 9.5%. Electrophoretic mobility shift assay
(EMSA), showed that 30min of FSDC exposure to NiSO4 activates the
transcription factor NF-kB by 58.2+ 7.0% and 2h of FSDC exposure to
NiSO4 activates the transcription factor AP-1 by 26.0+ 1.4%. Together,
these results indicate that NiSO4 activates the NF-kB and AP-1 pathways
and induces iNOS expression in skin dendritic cells.
Introduction
Skin dendritic cells (DCs) play an important role
in the initiation of the allergic contact reaction by
primary activation of naive specific T cells. Critical
events of the sensitization phase include the acti-
vation of resident DC in the epidermis and dermis
(1,2). Immature skin dendritic cells capture and
process the antigens and then migrate to T-cell
areas of lymphoid organs where they lose anti-
gen-processing activity and mature to become
potent immunostimulatory cells. Dendritic-cell dif-
ferentiation and maturation require the activation
of the mitogen-activated protein kinase (MAPK)
(3) and the transcription nuclear factor kappa B
(NF-kB) (4–7).
Nickel is the most frequent cause of contact
allergy (8). This hapten significantly increases
the expression of dendritic cell-surface markers
essential for antigen presentation, such as the
major histocompatibility complex class II mol-
ecules (MHC II) and costimulatory molecules, and
increases the antigen-presenting function of these
cells (9–11,3). However, the signal transduction
pathways involved in nickel-induced DC matur-
ation are still poorly characterized.
We have previously reported that in a fetal skin
dendritic cell line (FSDC) exhibiting functional
characteristics of a DC precursor, lipopolysacchar-
ide (LPS) and granulocyte-macrophage colony-
stimulating factor activate the transcription factor
NF-kB and induce the expression of type II
isoform of nitric oxide synthase (iNOS) (12,13).
Nitric oxide (NO) is a highly reactive radical pro-
duced from the amino acid L-arginine, by the
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enzyme NO synthase (14), and appears to be
involved in skin growth and remodeling (15–18),
in skin inflammatory processes (19–21) and in
modulating antigen presentation (22–25).
The transcription nuclear factor kappa B (NF-
kB) and the transcription factor activating protein 1
(AP-1) are ubiquitous transcription factors and
pleiotropic regulators of the inducible expression
of many genes that encode proteins involved in
the modulation of inflammatory and host defense
processes in eukaryotic cells, namely the iNOS gene
(26,27). The promoter region of the iNOS gene
contains binding sites for the transcription factors
NF-kB and AP-1 (28,29). In resting cells, NF-kB
proteins (p50, p52, p65/RelA, RelB, and c-Rel) are
localized in the cytosol in associationwith the inhibi-
tory proteins called IkB. Cell activation by various
stimuli results in IkB protein phosphorylation and
degradation, which in turn leads to the transloca-
tion of NF-kB proteins to the nucleus, where they
up-regulate gene expression(30). The transcription
factor AP-1 is composed of homo and hetero-
dimeric complexes of Jun (c-Jun, Jun B, Jun D),
Fos (c-Fos, Fos B, Fra-1 and Fra-2) and activating
transcription factor (ATF) family proteins, and
regulates gene transcription by interacting with the
DNA-regulatory elements. Depending on the com-
position of the dimmer, different sequence elements
are preferentially recognized (27).
The aim of this study was to know whether the
contact sensitizer nickel sulfate (NiSO4) induced
iNOS expression and NO production in a FSDC.
Moreover, we also studied whether NiSO4 acti-
vates the transcription factors NF-kB and AP-1
in skin DCs.
Materials and Methods
Materials
Nickel sulfate was from Sigma Chemical Co. (St. Louis, MO).
The rabbit antimouse iNOS polyclonal antibody was purchased
from Transduction Laboratories (Lexington, KY), and the rabbit
antihuman NF-kB p65 was from Serotec (Oxford, UK). The
fluorescein isothiocyanate (FITC)-conjugated swine antirabbit
immunoglobulin was from DAKO (Copenhagen, Denmark).
The mounting medium for fluorescence, Vectashield, was
obtained from Vector Laboratories, Inc. (Burlingame, CA). The
NF-kB and AP-1 consensus oligonucleotide, the rabbit anti-
mouse NF-kB RelB, the rabbit antihuman NF-kB p50, the goat
antimouse NF-kB cRel and the rabbit antimouse NF-kB p52
were obtained from Santa Cruz Biotechnology (Santa Cruz,
CA). The rabbit antibodies against the proteins Fra-1, Fra-2,
c-Jun, Fos B, ATF-2, Jun B and Jun D and the mouse antibody
against the c-Fos protein were obtained from Santa Cruz Bio-
technology (Santa Cruz). The horseradish peroxidase-conjugated
goat antimouse was from Pierce (Rockford, IL). The 32P-labeled
g-ATP, the T4 polynucleotide kinase, the poly (dI-dC)-poly
(dI-dC), ECL Western blotting analysis system, horseradish
peroxidase-conjugated donkey antirabbit immunoglobulin and
the X-ray films were from Amersham Biosciences (Carnaxide,
Portugal). The fetal calf serum was from Biochrom KG (Berlin,
Germany) and trypsin from Invitrogen (Paisley, UK). Triton1
100 and paraformaldehyde were from VWR International/
Merck Eurolab (Lisboa, Portugal). The protease inhibitor cock-
tail and the mouse monoclonal antibody against actin were from
Roche (Carnaxide, Portugal). All other reagents were from Sigma
Chemical Co.
Cell culture
The fetal mouse skin dendritic cell line FSDC was kindly supplied
by Dr G. Girolomoni (31). The cells were cultured in endotoxin
free Iscove’s modified Dulbeccos’ medium supplemented with
10% (v/v) fetal calf serum, 1% (w/v) glutamine, 3.02 g/l sodium
bicarbonate, 100mg/ml of streptomycin and 100U/ml of penicil-
lin. For Western blot and electrophoretic mobility shift assay
(EMSA) analysis, the FSDCs were plated at 2 106 cells/wells
in six-well culture plates for 24h before treatment, whereas for
nitrite measurements the cells were plated at 0.2 106 cells/wells
in 48-well culture plates. For immunofluorescence analysis, the
FSDC cells were grown on a Laboratory-Tek chamber slide with
cover (0.2 106 cells/slide) for 24h before treatment.
Nitrite measurement
The production of NOwas accessed as the accumulation of nitrite
(NO2
–) in the culture supernatants, using a colorimetric reaction
with the Griess reagent (32). Briefly, after FSDC stimulation with
different concentrations of NiSO4 (1–100mg/ml), for 48h, the
culture supernatants were collected and diluted with equal
volumes of the Griess reagent [0.1% (w/v) N-(1-naphthyl) ethyl-
enediamine dihydrochloride, 1% (w/v) sulphanilamide:5% (w/v)
H3PO4] for 10min. The absorbance at 550 nm was measured,
after a 20-min incubation, in an automated plate reader (SLT,
Salzburg, Austria). The nitrite concentration was determined
from a sodium nitrite standard curve.
Western blot analysis
For immunodetection of iNOS, cells were treated with culture
medium (control) or with NiSO4 (100mg/ml). After treatment,
cells were washed with PBS, and total cell lysates were obtained
after harvesting the cells in sonication buffer containing 0.32M
of sucrose, 10mM of Tris-HCl, pH7.5, 1mM of ethylene-
diaminetetraacetic acid, 1mMof dithiothreitol, 0.1mMof phenyl-
methylsulfonylfluoride and the protease inhibitor cocktail.
Then, the lysates were incubated on ice for 30min and sonicated
on ice at low amplitude (four times for 4 s at 20mmpeak to peak) to
disrupt the cells. Protein concentration was determined using the
bicinchoninic acid method. Protein samples were separated on a
10% (v/v) SDS-PAGE, and transferred to a polyvinylidene difluor-
ide (PVDF)membrane. Themembrane was blocked with 5% (w/v)
dry milk in Tris-buffered saline with 0.1% (v/v) Tween 20, for 1h.
The level of iNOS protein was detected using a rabbit polyclonal
antimouse iNOS antibody (1 : 2000) for 1h, followed by incubation
with a horseradish peroxidase-conjugated swine antirabbit anti-
body (1 : 5000). The immunocomplexes were visualized by the
enhanced chemiluminescence (ECL) chemiluminescence method.
To demonstrate equivalent protein loading the membrane was
stripped and reprobed with an antiactin antibody (1 : 10000).
Immunofluorescence microscopy
For immunofluorescence analysis, FSDC cells grown on the
Laboratory-Tek chamber slide with cover (0.2 106 cells/slide)
were treated for 24h with NiSO4 (50 and 100mg/ml). The cells
were thenwashedwithPBSand fixedwithPBS containing 4%(w/v)
sucrose and 4% (w/v) paraformaldehyde for 15min, and then
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the FSDCs were permeabilized in PBS containing 1% (v/v)
Triton1 100 for 10min. Non-specific binding was blocked by
incubating the cells with PBS supplemented with normal swine
serum (1 : 20) and with 0.5% (w/v) BSA for 45min at room
temperature. Cells were then incubated for 90min at room tem-
perature with a rabbit polyclonal antibody directed against mouse
iNOS (10mg/ml). After rinsing with PBS the cells were incubated
with FITC-conjugated swine antirabbit immunoglobulin (1 : 40
dilution) in 0.5% BSA-PBS for 45min. The chamber slide was
rinsed and mounted with the mounting medium for fluorescence,
Vectashield. Cells labeled with FITC-anti iNOS were photo-
graphed on a Zeiss Axioskop microscope (Zeiss, Oberkochen,
Germany). Control experiments consisted of processing the same
preparations as described, except for omitting the primary anti-
body, and resulted in no specific staining.
Electrophoretic mobility shift assay
The FSDC cells were treated for 15min, 30min and 2h with
NiSO4 (100mg/ml). The cells were then washed with PBS and
lysed in 10mM of NaCl, 3mM of MgCl2, 0.5% (v/v) Nonidet
P-40, 1mM of dithiothreitol, 0.1mM of phenylmethylsulfonyl-
fluoride, 10mM of Tris-HCl (pH7.5) and the protease inhibitor
cocktail. The lysates were incubated on ice for 15min and cen-
trifuged at 2300 g, for 10min. The pellet obtained was resus-
pended in 300mM of NaCl, 3mM of MgCl2, 20% (v/v) glycerol,
1mM of dithiothreitol, 0.1mM of phenylmethylsulfonylfluoride,
0.2mM of EDTA, 20mM of HEPES buffer (pH7.5) and the
protease inhibitor cocktail, incubated on ice for 1 h, and centri-
fuged at 12000 g, for 20min. The supernatant containing the
nuclear proteins was collected, and protein concentration was
determined using the bicinchoninic acid solution. The EMSA
method used was similar to that described previously (26), with
slight modifications. The probes consisted of a double-stranded
oligonucleotide containing the consensus binding sequence for
NF-kB (50-AGT TGA GGG GAC TTT CCC AGG C-30), or
for AP-1(50-CGC TTG ATG ACT CAG CCG GAA-30) end-
labeled with [g-32P]ATP using T4 polynucleotide kinase. Typical
binding reactions consisted of 15mg of nuclear extract, 150,000
c.p.m. of [g-32P]-labeled oligonucleotide, and 100mg/ml of poly
(dI-dC).poly (dI-dC), in a buffer containing 20mM of HEPES
(pH7.9), 1mM of MgCl2, 4% (w/v) Ficoll 400, 0.5mM of dithio-
threitol, 50mM of KCl, and 1mg/ml of BSA, and were incubated
at room temperature for 45min. Binding reactions were separated
on 7% (v/v) non-denaturing polyacrylamide gels, in a buffer system
containing 0.044 M of Tris-Base (pH8.0), 44.5mM of boric acid
and 1mM of EDTA, at a constant voltage of 150V, for 2h and
15min at room temperature. The gels were transferred to What-
man paper, dried, and subjected to autoradiography. In competi-
tion experiments, an unlabeled oligonucleotide was added to the
nuclear extracts for 30min before addition of a radiolabeled probe.
To detect supershifted bands, specific antibodies (2mg) against the
NF-kB and AP-1 proteins were incubated with the nuclear extracts
for 30min before addition of the radiolabeled probe.
Data analysis
Results are presented as mean+ SEM of the indicated number of
experiments. Mean values were compared using the Student’s
two-tailed unpaired t-test.
Results
Nickel sulfate increases the production of nitric
oxide and the expression of iNOS in FSDC cells
The enzymatic production of NO by the FSDCs
was evaluated by the measurement of nitrite
concentration in the culture medium. As shown in
Fig. 1, stimulation of the cells with NiSO4 (1–100
mg/ml) for 48h caused a dose-dependent increase in
nitrite production, from 100% when the FSDCs
were incubated with culture medium alone to
127.6+ 9.5% when the FSDCs were incubated
with 25mg/ml of Ni (P< 0.05). The assay of cellular
MTT reduction did not show any significant toxic
effect induced by NiSO4 for the concentrations used
in these experiments (data not shown).
Western blot was used to examine whether
NiSO4 regulates the expression of iNOS protein
(130kDa). As indicated in Fig. 2(a), non-stimulated
cells express iNOS (lane 1), but the expression of
the protein increased to 131.9+ 10.3% of the
control upon stimulation with 100mg/ml of NiSO4,
for 24 h (Fig. 2b) (P< 0.05). The basal expression
of the iNOS protein in the control cells was
probably a result of the presence of FCS (10%)
in the culture medium, which per se activates the
cells.
Immunocytochemistry of the iNOS protein
induction by nickel sulfate in FSDCs
Immunofluorescent labelling of FSDC cells with
the antiiNOS polyclonal antibody was markedly
increased in cells stimulated with 50mg/ml of
NiSO4 (Fig. 3b) and 100mg/ml of NiSO4 (Fig. 3c),
as compared with the cells maintained in culture
medium (Fig. 3a). These results are in agreement
with those obtained by Western blot (Fig. 2)
and indicate that the expression of iNOS is
up-regulated by the sensitizer NiSO4 in FSDCs.
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Figure 1. The sensitizer nickel sulfate increased nitrite production
in the fetal skin-derived dendritic cell line. Fetal skin-derived
dendritic cell line cells (0.2 106 cells) were maintained in culture
medium (control) or were incubated for 48h with different
concentrations of nickel sulfate (1–100mg/ml). Nitrite levels in the
culture supernatants were detected by the Griess reaction, as
described in experimental procedures. Each value represents the
mean+SEM from eight experiments performed in duplicate
(*P< 0.05).
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Nickel sulfate induces NF-kB and AP-1 binding to
DNA in FSDC cells
As the promoter region of the iNOS gene contains
binding sites for NF-kB and AP-1 (28,29) we
examined whether the contact sensitizer nickel
activates these two transcription factors.
The FSDCs were stimulated with NiSO4
(100mg/ml) for 15min and 30min, and maximal
NF-kB binding to DNA (Fig. 4) was observed
within a period of 30min (lane 3). As indicated
in Fig. 4(a), the NF-kB binding to DNA increased
to 158.2+ 7.0% of the control upon stimulation
with 100mg/ml of NiSO4, for 30min (P< 0.001).
Supershift experiments using antibodies against
the subunits of NF-kB indicated that the anti-
bodies against p65 (lane 6), RelB (lane 7) and cRel
(lane 8) proteins decreased NF-kB complex forma-
tion (Fig. 4b). Unlabeled oligonucleotide (100-fold
in excess) was used as a control for the gel shift
assays (lane 2), and inhibited the NF-kB complex
formation. In contrast, the antibodies against the
subunits of NF-kB p50 (lane 4) and p52 (lane 5)
were without effect on NF-kB complex formation
(Fig. 4b).
As AP-1 activation requires de novo protein
synthesis, we incubated FSDC cells with the con-
tact sensitizer for 1 and 2h. Figure 5(a) shows that
stimulation of FSDCs with NiSO4 (100mg/ml)
increases AP-1 binding to DNA within a period
of 2h (from 100% in control cells to 126+ 1.4%,
P< 0.001). Supershift experiments using anti-
bodies against the different proteins of AP-1 (Fra-1,
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Figure 2. The sensitizer nickel sulfate (NiSO4) increased the
isoform of nitric oxide synthase protein expression in the fetal
skin-derived dendritic cell line. Fetal skin-derived dendritic cell
line cells (2 106 cells) were incubated for 24h in culture medium
alone (control, lane 1) or in the presence of 100mg/ml of NiSO4
(lane 2). Total cell extracts were electrophoresed through SDS-
PAGE, transferred to PVDF membranes and subjected to
Western blot analysis using an antiiNOS antibody. The
membrane was stripped and reprobed with an antiactin
antibody to confirm equal protein loading (a). The bands were
quantified with an image analyzer. Each value represents the
mean+SEM from four experiments (*P< 0.05) (b). iNOS¼
inducible nitric oxide synthase.
(a) Control
(b) Ni (50 µg/ml)
(c) Ni (100 µg/ml)
Figure 3. Immunocytochemistry of the
isoform of nitric oxide synthase protein
increased by the sensitizer nickel sulfate
in the fetal skin-derived dendritic cell
line. Fetal skin-derived dendritic cell line
cells (0.2 106 cells) were maintained for
24h in culture medium in the absence (a)
or presence of 50mg/ml of nickel sulfate
(b), or 100mg/ml of nickel sulfate (c).
Immunostaining was performed as
described in Materials and Methods.
Scale bars¼ 25 micrometers (left panel-
magnification 100; right panel-
magnification 250).
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Figure 4. The sensitizer nickel sulfate induced nuclear factor
kappa activation in fetal skin-derived dendritic cell line cells.
Fetal skin-derived dendritic cell line cells (2 106 cells) were
incubated for 30min in culture medium alone (control, lane 1) or
in the presence of 100mg/ml of nickel sulfate (lane 3). Nuclear
extracts were subjected to electrophoretic mobility shift assay
analysis, as described in experimental procedures. These bands
were quantified with an image analyzer. Each value represents
the mean+ SEM from four experiments (***P< 0.001) (a).
Supershift experiments were performed using specific antip50,
antip52, antip65, antiRelB and anticRel antibodies (lanes 4–8).
To demonstrate specificity of induced bands, binding was carried
out in the presence of a molar excess (100) of non-radioactive
oligonucleotide containing the nuclear factor kappa B (NF-kB)
consensus sequence (lane 2). The gel shown is representative of
two gels yielding identical results (b).
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Figure 5. The sensitizer nickel sulfate induced activating protein-1
(AP-1) activation in fetal skin-derived dendritic cell line cells.
Fetal skin-derived dendritic cell line cells (2 106 cells) were
incubated for 2h, for the time periods indicated, in culture
medium alone (control, lane 1) or in the presence of 100mg/ml of
nickel sulfate (lane 2). Nuclear extracts were subjected to
electrophoretic mobility shift assay analysis, as described in
experimental procedures. These bands were quantified with an
image analyzer. Each value represents the mean+ SEM from
three experiments (***P< 0.001) (a). Supershift experiments
were performed using specific antiFra-1, antiFra-2, antic-Fos,
antiFos B, antiATF-2, antiJun B, antiJun D and antic-Jun
antibodies (lanes 3–10). To demonstrate specificity of induced
bands, binding was carried out in the presence of a molar excess
(100) of non-radioactive oligonucleotide containing the AP-1
consensus sequence (lane 11). The gel shown is representative of
two gels yielding identical results (b).
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Fra-2, c-Fos, Fos B, ATF-2, Jun B, Jun D and
c-Jun) were performed, and indicated that the anti-
bodies against Fra-1, Fra-2, c-Fos, Fos B (lanes
3–6), Jun B, Jun D and c-Jun (lanes 8–10) proteins
decrease AP-1 complex formation (Fig. 5b). In
contrast, the antibody against the protein ATF-2
(lane 7) was without effect on AP-1 complex
formation (Fig. 5b). Unlabeled oligonucleotide
(100-fold in excess) was used (lane 11) as a control
for the gel shift assays, and inhibited AP-1 complex
formation (Fig. 5b).
Discussion
In the present work, we have shown that the con-
tact sensitizer nickel sulfate (NiSO4) increases
iNOS expression and NO production in a FSDC
line (Figs 1–3). Moreover, exposure of FSDCs to
NiSO4 induced NF-kB and AP-1 binding to DNA
(Figs 4 and 5).
The list of immunological agents known to
induce iNOS gene expression in vivo and in vitro
has been growing in recent years (14), but few
reports exist concerning the effect of the contact
sensitizer nickel on NOS. Nickel was shown to
inhibit the constitutive neuronal NOS activity
(33,34), whereas in LPS- and cytokine-stimulated
macrophages the sensitizer nickel significantly
increased NO production (35,36).
The intracellular signaling pathways by which
NiSO4 induces iNOS expression in DCs are not
known. We have previously reported that in
FSDCs, LPS and GM-CSF induce IkB-a degrad-
ation, the translocation of NF-kB proteins into the
nucleus and the expression of iNOS (12,13). How-
ever, NO production induced by nickel (50mg/ml)
was 5.1- and 1.4-fold lower than that produced by
FSDCs stimulated with LPS (5mg/ml) and GM-
CSF (200ng/ml), respectively (37). Lipopolysac-
charide was shown to stimulate the production of
cytokines (38) and to induce maturation of human
monocyte-derived dendritic cells (39). Therefore,
LPS may cause NO production both directly and
indirectly, via the synthesis of cytokines that also
stimulate NO production. Interestingly, the
amount of NO production induced by nickel was
slightly higher (1.2-fold) than that produced by
FSDCs in response to TNF-a (37). These differ-
ences in the amount of NO produced by FSDCs
stimulated with LPS, GM-CSF, TNF-a and the
contact sensitizer nickel may be a result of the
activation of distinct signalling pathways, which
in turn increase the iNOS protein expression.
Accordingly, we demonstrated previously that
LPS induced iNOS expression through the Janus
kinase signalling pathway (12), in contrast to
recent results showing that contact sensitizers do
not activate this signalling pathway (40).
As the promoter region of the iNOS gene con-
tains binding sites for NF-kB and AP-1 (28,29) it is
possible that, in FSDCs, nickel sulfate increases
the iNOS expression through NF-kB or/and AP-1
activation. Accordingly, our results show that
NiSO4 induced activation of the transcriptor fac-
tors NF-kB and AP-1 (Figs 4 and 5). Nuclear
factor-kB activation by nickel was also reported
in endothelial cells (41,42). Moreover, in human
airway epithelial cells, nickel-induced interleukin-8
expression was shown to be dependent on AP-1
(43) and, in epithelial cells, nickel activates AP-1
through an oxidant-independent pathway (44).
Nickel was found to increase the production of
tumour necrosis factor a in DCs and to up-regulate
the expression of MHC, of the costimulatory
molecule CD80 in DCs (3,9,10), and of the
endothelial adhesion molecules in endothelial
cells (45). The genes that codified those proteins
contain NF-kB binding sites in their promoter
enhancer regions (46).
Most of the NF-kB inducers appear to rely on
the production of intracellular reactive oxygen
species, and the activity of the transcription factor
AP-1 is modulated by the intracellular redox state
(47). As nickel compounds are also able to cause
generation of reactive oxygen species (48,49), it is
possible that in FSDCs the sensitizer nickel gener-
ates reactive oxygen species, which in turn acti-
vates the NF-kB and AP-1 transcription factors
that bind to the iNOS gene promoter, thus indu-
cing iNOS protein expression. Accordingly, nickel
compounds are able to induce nuclear factor of
activated T cells (NFAT), and the mechanism of
NFAT activation seems to be mediated by the
generation of hydrogen peroxide (50). Another
mechanism of signal transduction induced by
nickel involves the activation of the p38 mitogen-
activated protein kinase (MAPK) (3,42). The p38
MAPK pathway was shown to contribute to AP-
1- and NF-kB-mediated transactivation (51–53).
These results also suggest that in FSDCs, nickel
may also activate protein kinases, namely p38
MAPK, which in turn induce NF-kB activation
and iNOS expression.
We have previously reported that in FSDCs the
strong sensitizer 2,4-dinitrofluorobenzene (DNFB)
induces the degradation of the inhibitor of NF-kB,
IkB-a and stimulates the translocation of the
NF-kB proteins into the nucleus (54), whereas
the nonsensitizer 2,4-dichloronitrobenzene was
without effect (data not shown). These results indi-
cate that in skin DCs the NF-kB is a pivotal
signalling pathway activated by contact sensitizers.
iNOS expression and transcription factors activation by nickel
23
Accordingly, it was recently demonstrated that
effective antigen presentation by DCs is NF-kB
dependent (55) and that the NF-kB proteins are
involved in DC differentiation and maturation
(4–7,56). The NF-kB signal transduction pathway
is also involved in the survival and maturation
of LPS-stimulated human monocyte-derived
dendritic cells (39). The NF-kB member RelB
is also involved in DC differentiation (57,58)
and in the transactivation of genes of central
importance for functional antigen-presenting cells
(59–61).
Although the strong sensitizer 2,4-dinitro-
fluorobenzene (DNFB) induced the NF-kB
pathway (54) it did not induce iNOS expression
in FSDCs (data not shown), in contrast with the
results obtained in this work, in which the sensi-
tizer nickel sulfate induced iNOS expression
(Figs 2 and 3). Moreover, the strong sensitizer
DNFB induced p50, p52 and RelB translocation
from the cytosol to the nucleus of FSDCs, and
was without effect on cRel protein (54), in con-
trast with the results obtained in this work, in
which the sensitizer nickel sulfate activated p65,
cRel and RelB proteins (Fig. 4). This differential
activation of nuclear factor kappa B subunits in
response to the different contact sensitizers
DNFB and nickel may explain the different
effects of those sensitizers on iNOS expression.
Accordingly, the NF-kB displays the capacity to
activate, in a cell-and stimulus-specific manner,
only a subset of the total repertoire of NF-kB-
responsive genes (62). In macrophages and DCs
the NF-kB pathway responds to different stimuli
in a cell-specific manner by activating unique
signalling pathways and subsets of NF-kB target
genes (63).
Significant physiological and physiopatho-
logical consequences have been associated with
NO production by skin cells. Nitric oxide
appears to be involved in skin physiology,
growth and remodeling (15–18). Being diffusible
across cells, NO produced by LCs regulates
lymphocyte proliferation by inhibiting or inducing
apoptosis (22,23). Nitric oxide is also involved in
skin inflammatory processes (19–21), and a sig-
nificant increase in iNOS protein was found in
both irritant and allergic contact dermatitis (64).
Therefore, NO produced by DCs may play an
important role in modulating the allergic derma-
titic response to contact allergens. A better
knowledge of the signaling pathways activated
by contact sensitizers in skin DCs, namely those
involved in iNOS expression, will contribute to
the identification of potential sites of therapeutic
intervention.
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